Wunderlich On Cybersecurity: Positive On Symantec And 2 Others, But Neutral On FireEye, Imperva

In a series of new notes out this week, Wunderlich analyst Bill Choi updated his outlook on several top cybersecurity stocks. Here’s an overview of what he had to say about each.

Buy-Rated Stocks

Symantec Corporation (NASDAQ: SYMC): Choi upgraded the stock from Hold to Buy and raised the firm’s price target from $23 to $30. He praised the company for its transition from a legacy security provider to a “next-gen security provider with updated solutions in enterprise, consumer, and now web/cloud security.”

Related Link: Symantec Attempting To Transition From Bulky Backup Company To Next-Gen Security Provider

Qualys Inc (NASDAQ: QLYS): Choi upgraded the stock from Hold to Buy and raised Wunderlich’s price target from $31 to $34. He sees a path to sustainable core vulnerability management (VM) growth of greater than 20 percent. In addition, he believes “investors are underappreciating the fundamental evolution” of the company’s core business.

Proofpoint Inc (NASDAQ: PFPT): Choi reiterated a Buy rating on the stock but upgraded his price target from $83 to $90. He praised the company’s focus on the human factor in cybersecurity, particularly email and social vulnerabilities. Choi expects Proofpoint “to outperform the overall cyber security market, given the existing opportunity to transition and upsell legacy McAfee customers.”

Neutral-Rated Cybersecurity Names

FireEye Inc (NASDAQ: FEYE): Choi reiterated the firm’s Hold rating on FireEye, but upped his price target from $15 to $16. He sees a tough road ahead for the company, especially given the uncertainty surrounding a change of CEOs and the departure of the founder. For now, Choi projects “limited upside to FEYE shares at current levels given the expected headwinds the company faces during the impending period of transition and restructuring.”

Imperva Inc (NYSE: IMPV): Choi reiterated Wunderlich’s Hold rating and $50 price target. For now, he believes significant upside hinges on the company finding a buyer. Although he doesn’t see any immediate financial danger, Choi believes “the cut to FY16 guidance, combined with the review of strategic alternatives, is enough to question IMPV’s standalone future.”

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!